These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 7745945

  • 1. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
    DeLellis RA.
    Lab Invest; 1995 May; 72(5):494-505. PubMed ID: 7745945
    [No Abstract] [Full Text] [Related]

  • 2. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
    Mulligan LM, Ponder BA.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
    [No Abstract] [Full Text] [Related]

  • 3. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G, Domené HM, Iorcansky S, Barontini M.
    Medicina (B Aires); 1998 Jul; 58(2):179-84. PubMed ID: 9706252
    [Abstract] [Full Text] [Related]

  • 4. [One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].
    Fehmann HC, Göke B.
    Z Gastroenterol; 1994 Jul; 32(7):416-7. PubMed ID: 7975780
    [No Abstract] [Full Text] [Related]

  • 5. Multiple endocrine neoplasia type 2.
    Forster-Gibson CJ, Mulligan LM.
    Eur J Cancer; 1994 Jul; 30A(13):1969-74. PubMed ID: 7734209
    [No Abstract] [Full Text] [Related]

  • 6. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
    Hofstra RM, van der Luijt RB, Lips CJ.
    Ned Tijdschr Geneeskd; 2001 Nov 17; 145(46):2217-21. PubMed ID: 11757244
    [Abstract] [Full Text] [Related]

  • 7. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
    Iihara M, Yamashita T, Okamoto T, Kanbe M, Yamazaki K, Egawa S, Yamaguchi K, Obara T.
    Jpn J Clin Oncol; 1997 Jun 17; 27(3):128-34. PubMed ID: 9255265
    [Abstract] [Full Text] [Related]

  • 8. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

  • 9. [Multiple endocrine neoplasia].
    Takami H, Ikeda Y, Kameyama K.
    Gan To Kagaku Ryoho; 2002 Apr 15; 29(4):508-11. PubMed ID: 11977533
    [Abstract] [Full Text] [Related]

  • 10. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.
    Stratakis CA.
    J Endocrinol Invest; 2001 May 15; 24(5):370-83. PubMed ID: 11407658
    [Abstract] [Full Text] [Related]

  • 11. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1995 May 15; 79():L-LV. PubMed ID: 8600671
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M, Jackson CE, Feldman GL.
    Hum Mutat; 1996 May 15; 8(1):64-70. PubMed ID: 8807338
    [Abstract] [Full Text] [Related]

  • 13. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z, Soliman E, Amizuka N, Janicic N, Konrad EM, Arnold A, Goltzman D, Hendy GN.
    J Clin Endocrinol Metab; 1996 Jul 15; 81(7):2711-8. PubMed ID: 8675600
    [Abstract] [Full Text] [Related]

  • 14. [Medullary thyroid gland carcinoma. Sporadic/familial. Screening when and why?].
    Frilling A, Liedke MO.
    Internist (Berl); 1998 Jun 15; 39(6):588-91. PubMed ID: 9677514
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M, Weinhüsel A, Niederle B, Haas OA.
    Int J Cancer; 1996 Aug 22; 69(4):312-6. PubMed ID: 8797874
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
    Heshmati HM, Hofbauer LC.
    Eur J Endocrinol; 1997 Dec 22; 137(6):572-8. PubMed ID: 9437218
    [No Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations.
    Takahashi M, Asai N, Iwashita T, Murakami H, Ito S.
    J Intern Med; 1998 Jun 22; 243(6):509-13. PubMed ID: 9681851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.